JNJ · News · 20261022N

Licensing / Collaboration Deals

JOHNSON & JOHNSON · 2026-10-22 · Importance 31 · Surprise 42

Johnson & Johnson was selected as a Strategic Enterprise by Hong Kong’s Office for Attracting Strategic Enterprises on October 22, 2026. The OASES collaboration is intended to strengthen clinical research and develop future healthcare talent in Hong Kong. The arrangement supports Hong Kong’s objective of becoming an international health and medical innovation hub. The reporting did not disclose a transaction value, investment commitment, or revenue contribution.